Detailansicht

Wissensnetz

Person

Manfred Welslau

Internist

Name	Manfred Welslau
Ort	Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Internist (charakteristischer Beruf)
Quelle	Vorlage
Datensatztyp	Person
GND-Nummer	1209579111
Datensatz-ID	1209579111
Beteiligt an alle anzeigen Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients Update breast cancer 2024 part 1 - expert opinion on advanced breast cancer Das HER2-positive metastasierte Mammakarzinom – aktuelle Behandlungskonzepte Das HER2-positive metastasierte Mammakarzinom – Aktuelle Behandlungskonzepte Update Mammakarzinom 2022 Teil 1 – Brustkrebs in frühen Krankheitsstadien Update Breast Cancer 2022 Part 1 – Early Stage Breast Cancer The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape Update breast cancer 2022 part 1 – early stage breast cancer Update breast cancer 2022 part 1 : early stage breast cancer Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients A prospective real-world multi-center study to evaluate progression-free and overall survival of radiotherapy with cetuximab and platinum-based chemotherapy with cetuximab in locally recurrent head and neck cancer A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer Update Breast Cancer 2020 Part 2 – Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Manfred Welslau

Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

Update breast cancer 2024 part 1 - expert opinion on advanced breast cancer

Das HER2-positive metastasierte Mammakarzinom – aktuelle Behandlungskonzepte

Das HER2-positive metastasierte Mammakarzinom – Aktuelle Behandlungskonzepte

Update Mammakarzinom 2022 Teil 1 – Brustkrebs in frühen Krankheitsstadien

Update Breast Cancer 2022 Part 1 – Early Stage Breast Cancer

The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape

Update breast cancer 2022 part 1 – early stage breast cancer

Update breast cancer 2022 part 1 : early stage breast cancer

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

A prospective real-world multi-center study to evaluate progression-free and overall survival of radiotherapy with cetuximab and platinum-based chemotherapy with cetuximab in locally recurrent head and neck cancer

A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

Update Breast Cancer 2020 Part 2 – Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer